Nishikawa, H., Nishijima, N., Enomoto, H., Sakamoto, A., Nasu, A., Komekado, H., . . . Osaki, Y. (2017). Predictive factors in patients with hepatocellular carcinoma receiving sorafenib therapy using time-dependent receiver operating characteristic analysis. J Cancer.
Dyfyniad Arddull ChicagoNishikawa, Hiroki, et al. "Predictive Factors in Patients With Hepatocellular Carcinoma Receiving Sorafenib Therapy Using Time-dependent Receiver Operating Characteristic Analysis." J Cancer 2017.
Dyfyniad MLANishikawa, Hiroki, et al. "Predictive Factors in Patients With Hepatocellular Carcinoma Receiving Sorafenib Therapy Using Time-dependent Receiver Operating Characteristic Analysis." J Cancer 2017.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.